90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease Patients

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 7, 2023

Primary Completion Date

April 24, 2024

Study Completion Date

April 24, 2024

Conditions
IBDCrohn DiseaseUlcerative Colitis
Interventions
OTHER

90Second IBD

Patients will receive 90SecondIBD weekly at no charge via text message or email linked to a website.Each 90SecondIBD letter has an attractive photo, 250 words of targeted information on a specific topic and 3 specific action suggestions on the first page. The second page is a seven-item quiz on attitudes and behavior on the designated topic. The reader gets immediate feedback and advice. The third page is a personal story of someone with IBD about this topic. Finally, there is an evaluation of the specific 90SecondIBD issue and an opportunity to recommend topics.

Trial Locations (1)

B3H 3A7

QEII Health Sciences Centre, Halifax

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

90 Second Health

UNKNOWN

collaborator

Takeda

INDUSTRY

lead

Jennifer Jones

OTHER